77
Participants
Start Date
January 1, 2019
Primary Completion Date
July 1, 2024
Study Completion Date
July 10, 2024
taVNS
TaVNS device (Elmmedicare, EC100, Shenzhen, China) was used to apply stimulation for patients. Stimulation parameters comprised an electrical current of 1 mA at a frequency of 20 Hz, with a waveform width of 1 ms \[18,28\]. Repurposed off-the-shelf devices were utilized for this purpose, with the stimulator generating single square-wave pulses lasting 1 ms each. Enhancing conductivity was achieved by wiping the ear with tap water. In the taVNS group received 12 weeks of treatment (30 min each time, once daily, 5 times per week).
Betahistine Mesylate tablet
Betahistine Mesylate tablet (Merislon, Eisai Co., Ltd., China) with the treatment of 6 mg 3 times a day.
China Beijing TongRen Hospital, Capital Medical University Beijing, China, Beijing
Beijing Tongren Hospital
OTHER